logo

Valeant Pharmaceuticals International (VRX.TO)



Trade VRX.TO now with
  Date
  Headline
9/5/2017 9:21:22 AM Valeant Division Ortho Dermatologics Submits NDA To FDA For Psoriasis Treatment IDP-118
8/8/2017 2:21:50 PM Valeant Cuts Revenue Outlook
8/8/2017 8:31:44 AM Valeant Cuts Revenue Forecast
8/8/2017 7:02:07 AM Valeant Posts Q2 Revenues Of $2.233 Bln
8/7/2017 4:06:19 PM Pershing Square Proposes Three Directors, Including Bill Ackman, For Election To ADP Board
8/1/2017 7:35:17 AM EyeGate Pharma Enrolls First Patient In Phase 2b Clinical Study Of EGP-437 For Cataract Surgery
7/27/2017 7:19:02 AM Valeant Announces U.S. Launch Of SILIQ (brodalumab) Injection
7/27/2017 7:01:58 AM Valeant Announces U.S. Launch Of SILIQ Injection
7/17/2017 7:03:21 AM Valeant To Sell Its Obagi Medical Products Business For $190 Mln In Cash
7/13/2017 8:32:18 AM Valeant Announces Redemption Of Remaining $500 Mln Of Its Outstanding 6.75% Senior Notes Due 2018
7/13/2017 8:32:12 AM Valeant To Redeem The Remaining $500 Mln Of Its Outstanding 6.75% Senior Notes Due 2018
7/10/2017 7:02:33 AM Valeant Pharma Says Uses Dendreon Pharma Sale Proceeds To Pay Down $811 Mln Of Its Senior Secured Term Loans
7/6/2017 7:01:48 AM Valeant: Bausch + Lomb Introduces Bausch + Lomb AQUALOX Contact Lenses
6/29/2017 7:00:55 AM Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group